These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2690164)

  • 21. Intravenous clomipramine for obsessive-compulsive disorder.
    Koran LM; Faravelli C; Pallanti S
    J Clin Psychopharmacol; 1994 Jun; 14(3):216-8. PubMed ID: 8027426
    [No Abstract]   [Full Text] [Related]  

  • 22. Possible development of the serotonin syndrome in man.
    Insel TR; Roy BF; Cohen RM; Murphy DL
    Am J Psychiatry; 1982 Jul; 139(7):954-5. PubMed ID: 7091416
    [No Abstract]   [Full Text] [Related]  

  • 23. [Drug treatment of obsessive-compulsive disorders--a comparative study of the effectiveness of clomipramine and fluoxetine].
    Volk S
    Fortschr Neurol Psychiatr; 1995 Jun; 63 Suppl 1():28-32. PubMed ID: 7635392
    [No Abstract]   [Full Text] [Related]  

  • 24. Plasma concentrations of clomipramine and desmethylclomipramine in obsessive-compulsive neurosis.
    Luscombe DK; Wright J; Stern RS; Mawson D; Marks IM
    Postgrad Med J; 1980; 56 Suppl 1():140-3. PubMed ID: 7393825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluoxetine-clomipramine interaction.
    Sternbach H
    J Clin Psychiatry; 1995 Apr; 56(4):171-2. PubMed ID: 7713858
    [No Abstract]   [Full Text] [Related]  

  • 26. Anorgasmia from clomipramine in obsessive-compulsive disorder. A controlled trial.
    Monteiro WO; Noshirvani HF; Marks IM; Lelliott PT
    Br J Psychiatry; 1987 Jul; 151():107-12. PubMed ID: 3315086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Possible serotonin syndrome associated with clomipramine after withdrawal of clozapine.
    Zerjav-Lacombe S; Dewan V
    Ann Pharmacother; 2001 Feb; 35(2):180-2. PubMed ID: 11215836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interim analysis clarification.
    Liebowitz MR; Foa EB; Kozak MJ
    J Clin Psychiatry; 1995 Sep; 56(9):435. PubMed ID: 7665548
    [No Abstract]   [Full Text] [Related]  

  • 29. Obsessive-compulsive disorder.
    Insel TR
    Psychiatr Clin North Am; 1985 Mar; 8(1):105-17. PubMed ID: 3887336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clomipramine in obsessive-compulsive ritualisers treated with exposure therapy: relations between dose, plasma levels, outcome and side effects.
    Kasvikis Y; Marks IM
    Psychopharmacology (Berl); 1988; 95(1):113-8. PubMed ID: 3133689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A manic episode in a female patient with obsessive-compulsive disorder treated with chlorimipramine].
    Bernardo M; Vieta E; Vallejo J
    Med Clin (Barc); 1989 Oct; 93(10):395. PubMed ID: 2607791
    [No Abstract]   [Full Text] [Related]  

  • 32. Clomipramine-induced urinary dysfunction in an obsessive-compulsive adolescent.
    Hermesh H; Aizenberg D; Weizman A; Lapidot M; Munitz H
    Drug Intell Clin Pharm; 1987 Nov; 21(11):877-9. PubMed ID: 3678059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clomipramine discontinuation-emergent dystonia.
    Duggal HS; Dutta S; Sinha VK
    Aust N Z J Psychiatry; 2001 Oct; 35(5):696. PubMed ID: 11551294
    [No Abstract]   [Full Text] [Related]  

  • 34. [Withdrawal reactions after clomipramine].
    Zemishlany Z; Aizenberg D; Hermesh H; Weizman A
    Harefuah; 1992 Oct; 123(7-8):252-5, 307. PubMed ID: 1459499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Introduction of chronopharmacologic therapy of depressive disorders--a double-blind study using clomipramine].
    Nagayama H; Nagano H; Ikezaki A; Tashiro T
    Seishin Shinkeigaku Zasshi; 1989; 91(9):642-7. PubMed ID: 2623090
    [No Abstract]   [Full Text] [Related]  

  • 36. [Severe withdrawal symptoms following use of clomipramine].
    Kraft TB
    Ned Tijdschr Geneeskd; 1977 Aug; 121(33):1293. PubMed ID: 895917
    [No Abstract]   [Full Text] [Related]  

  • 37. Fluoxetine for clomipramine withdrawal symptoms.
    Benazzi F
    Am J Psychiatry; 1999 Apr; 156(4):661-2. PubMed ID: 10200756
    [No Abstract]   [Full Text] [Related]  

  • 38. Rebound antidepressant cardiac arrhythmia.
    Van Sweden B
    Biol Psychiatry; 1988 Jul; 24(3):363-4. PubMed ID: 2456791
    [No Abstract]   [Full Text] [Related]  

  • 39. Partial status epilepticus following single low dose of chlorimipramine in a patient on MAO-inhibitor treatment.
    Pascual J; Combarros O; Berciano J
    Clin Neuropharmacol; 1987 Dec; 10(6):565-7. PubMed ID: 3427564
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical and research issues in depersonalization syndrome.
    Hollander E; Hwang MY; Mullen LS; DeCaria C; Stein DJ; Cohen L
    Psychosomatics; 1993; 34(2):193-4. PubMed ID: 8456168
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.